2-(Dimethylaminomethyl)-tetrahydroisoxazolopyridobenzazepine derivatives. Synthesis of a new 5-HT2C antagonist with potential anxiolytic properties
摘要:
Following the program started at Johnson & Johnson Pharmaceutical Research & Development searching for 5-HT2A/2C antagonists, we now report on the synthesis of 2-(dimethylaminomethyl)-2,3,3a,8-tetrahydroisoxazolo[3,2-a]pyrido[3,4-c]-[2]benzazepine and 2-(dimethylaminomethyl)-2,3,3a,8-tetrahydroisoxazolo[3,2-a]pyrido[3,2-c]-[2]benzazepine. A new method for the synthesis of pyridobenzazepines is described as well. The affinities for several receptors as well as the mCPP antagonistic activity of the compounds synthesised are described. (C) 2002 Elsevier Science Ltd. All rights reserved.
FIRL, JOACHIM;MAIER, WALTER;DAAKE, HEINZ, LIEBIGS ANN. CHEM.,(1989) N, C. 469-475
作者:FIRL, JOACHIM、MAIER, WALTER、DAAKE, HEINZ
DOI:——
日期:——
N-acylated tricyclic azaheterorings useful as vasopressin antagonists
申请人:American Cyanamid Company
公开号:EP0640592B1
公开(公告)日:1998-12-30
[EN] TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS<br/>[FR] BENZAZEPINE TRICYCLE ANTAGONISTE DE LA VASOPRESSINE
申请人:AMERICAN CYANAMID COMPANY
公开号:WO1996022282A1
公开(公告)日:1996-07-25
(EN) Tricyclic compound of general formula (I) as defined herein which exhibit antagonist activity at V1 and/or V2 receptors and exhibit $i(in vivo) vasopressin antagonist activity, methods for using such compounds in treating diseases characterized by excess renal reabsorption of water, and process for preparing such compounds.(FR) L'invention porte sur des composés tricycliques de formule générale (I) présentant une activité antagoniste vis à vis des récepteurs V1 et V2 et une activité $i(in vivo) antagoniste de la vasopressine, sur des procédés d'utilisation de ces composés pour le traitement de maladies caractérisées par un excès de réabsorption rénale d'eau et sur un procédé de préparation desdits composés.